BACKGROUND/AIMS: Seven genomic loci, implicated by single nucleotide polymorphisms (SNPs), have recently been associated with progression to advanced fibrosis (fibrosis risk) in patients with chronic hepatitis C virus. Other variants in these loci have not been examined but may be associated with fibrosis risk independently of or due to linkage disequilibrium with the original polymorphisms. METHODS: We carried out dense genotyping and association testing of additional SNPs in each of the 7 regions in Caucasian case control samples. RESULTS: We identified several SNPs in the toll-like receptor 4 (TLR4) and syntaxin binding protein 5-like (STXBP5L) loci that were associated with fibrosis risk independently of the original significant SNPs. Haplotypes consisting of these SNPs in TLR4 and STXBP5L were strongly associated with fibrosis risk (global P=3.04 x 10(-5) and 4.49 x 10(-6), respectively). CONCLUSIONS: Multiple variants in TLR4 and STXBP5L genes modulate risk of liver fibrosis. These findings are of relevance for understanding the pathogenesis of HCV-induced liver disease in Caucasians and may be extended to other ethnicities as well.
BACKGROUND/AIMS: Seven genomic loci, implicated by single nucleotide polymorphisms (SNPs), have recently been associated with progression to advanced fibrosis (fibrosis risk) in patients with chronic hepatitis C virus. Other variants in these loci have not been examined but may be associated with fibrosis risk independently of or due to linkage disequilibrium with the original polymorphisms. METHODS: We carried out dense genotyping and association testing of additional SNPs in each of the 7 regions in Caucasian case control samples. RESULTS: We identified several SNPs in the toll-like receptor 4 (TLR4) and syntaxin binding protein 5-like (STXBP5L) loci that were associated with fibrosis risk independently of the original significant SNPs. Haplotypes consisting of these SNPs in TLR4 and STXBP5L were strongly associated with fibrosis risk (global P=3.04 x 10(-5) and 4.49 x 10(-6), respectively). CONCLUSIONS: Multiple variants in TLR4 and STXBP5L genes modulate risk of liver fibrosis. These findings are of relevance for understanding the pathogenesis of HCV-induced liver disease in Caucasians and may be extended to other ethnicities as well.
Authors: Yonghong Li; Petra Nowotny; Peter Holmans; Scott Smemo; John S K Kauwe; Anthony L Hinrichs; Kristina Tacey; Lisa Doil; Ryan van Luchene; Veronica Garcia; Charles Rowland; Steve Schrodi; Diane Leong; Goran Gogic; Joanne Chan; Anibal Cravchik; David Ross; Kit Lau; Shirley Kwok; Sheng-Yung Chang; Joe Catanese; John Sninsky; Thomas J White; John Hardy; John Powell; Simon Lovestone; John C Morris; Leon Thal; Michael Owen; Julie Williams; Alison Goate; Andrew Grupe Journal: Proc Natl Acad Sci U S A Date: 2004-10-26 Impact factor: 11.205
Authors: Marcus Mühlbauer; Anja K Bosserhoff; Arndt Hartmann; Wolfgang E Thasler; Thomas S Weiss; Hans Herfarth; Guntram Lock; Jürgen Schölmerich; Claus Hellerbrand Journal: Gastroenterology Date: 2003-10 Impact factor: 22.682
Authors: S Lilly Zheng; Katarina Augustsson-Bälter; Baoli Chang; Maria Hedelin; Liwu Li; Hans-Olov Adami; Jeanette Bensen; Ge Li; Jan-Erik Johnasson; Aubrey R Turner; Tamara S Adams; Deborah A Meyers; William B Isaacs; Jianfeng Xu; Henrik Grönberg Journal: Cancer Res Date: 2004-04-15 Impact factor: 12.701
Authors: Andrew J Paris; Zohar Snapir; Cindy D Christopherson; Shirley Y Kwok; Ursula E Lee; Zahra Ghiassi-Nejad; Peri Kocabayoglu; John J Sninsky; Josep M Llovet; Chaim Kahana; Scott L Friedman Journal: Hepatology Date: 2011-12 Impact factor: 17.425
Authors: Marcin Krawczyk; Roman Müllenbach; Susanne N Weber; Vincent Zimmer; Frank Lammert Journal: Nat Rev Gastroenterol Hepatol Date: 2010-11-02 Impact factor: 46.802